Open AccessP037 Effect of Ozanimod Treatment and Discontinuation on Absolute Lymphocyte Count in Moderate-to-Severe Ulcerative Colitis: Results from a Phase 3 Trial
Author(s) -
Colombel Jf,
Geert DʼHaens,
Peter Irving,
AnnKatrin Petersen,
Denesh K. Chitkara,
Marta Callejas,
Tianlei Chen,
L Charles,
Silvio Danese,
Subrata Ghosh
Publication year - 2021
Publication title -
the american journal of gastroenterology
Language(s) - English
Resource type - Journals
SCImago Journal Rank - 2.907
H-Index - 252
eISSN - 1572-0241
pISSN - 0002-9270
DOI - 10.14309/01.ajg.0000798748.09138.3f
Subject(s) - medicine , ulcerative colitis , placebo , population , pathology , disease , alternative medicine , environmental health